openPR Logo
Press release

Mastitis Market 2019 Share Analysis with Pfizer, Novartis AG, Sanofi S.A., AstraZeneca, Genentech Etc. Till 2023

02-27-2019 08:12 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Mastitis Market

Mastitis Market

The Global Mastitis Market is expected to reach over 18,338 Million USD by 2023, growing at approximately 15.07% CAGR during the forecast period (2017-2023). In the year 2017, the market had valued at USD 7,898.05 Million.

Mastitis Market - Key Players

Some of key the players in the market are Pfizer (U.S.), Novartis AG (Switzerland), Oncogenex (U.S.), Apthera Inc (U.K), BioNumerik Pharmaceuticals (U.S.), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (U.S.), Puma Biotechnology (U.S.), Sanofi S.A. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (U.K), Genentech (U.S), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (U.S.), and others.

Mastitis Market - Segmentation

For the convenience of the report and enhanced understanding; Market is segmented in to 4 key dynamics;

By Types: Comprises Invasive Lobular Carcinoma, Invasive Ductal Carcinoma, and other.

By Treatment: Chemotherapy (Antimetabolites, Anthracyclines, Taxanes & Alkylating Agents), Surgery & Radiation Therapy, Targeted Therapy (Tyrosine Kinase Inhibitors &Monoclonal Antibodies), Biologic Therapy, Hormone Therapy (selective estrogen-receptor modulators (SERMs), aromatase inhibitors) etc.

By End Users: Private Pharmacies and Hospital Pharmacies, etc.

By Regions: APAC, North America, Europe, and Rest of the World.

Segment Chemotherapy holds the largest share as in 45% of the market.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/5379

Mastitis Market – Insights

Mastitis refers to a kind of infection occurring in the tissues of mammary glands in the breast. The mastitis usually affects women who are breastfeeding as a result of a blocked duct. In cows, mastitis occurs as a result of chemical, mechanical, or thermal injury to the cow's udder.

In addition to the adoption of unhealthy lifestyle other factors driving the market growth include, increasing female geriatric population, exposure to harmful radiation, heredity reasons and genetic mutations (abnormal changes) coupled with the increasing governmental initiatives. Unavailability of absolute treatment presages the large scope for the market to evolve further and prompting to pharmaceutical companies to invest increasingly in R&D to discover novel more effective medicines.

Conversely, high costs pertaining to the treatments, long approval time for the drugs along with the adverse effects associated with therapies are restricting the market growth. Nevertheless, advent Mastitis treatments brought forward during the past few years and the approval of medication called CDK45 Inhibitors, has impacted the market in a big way. CDK45 Inhibitors when used in combination with endocrine therapy for positive Mastitis hormone-receptor, patients have shown improvements in survival – up to 10 months. Additionally, factors such as innovations, e.g. 3-D digital tomosynthesis imaging, Mammography allowing a clearer view through dense breast tissue and changes such as signed bill into law that allows commercial insurance providers to cover breast screening, including 3-D mammography are expected to provide impetus to the market growth.

Mastitis Market - Regional Analysis

The Americas mastitis market is expected to show extensive growth owing to increasing number of patient population for mastitis, and technological advancement in the healthcare. Moreover, high health care spending and increasing government support for research & development are expected to boost the market growth.

Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating mastitis and increasing investment in healthcare domain to improve treatment methods of rare diseases will fuel the growth of the market. The growing public awareness will boost the European market.

The Asia Pacific is the fastest growing mastitis market across the globe. Japan holds the major share of the regional market due to the availability of technology and huge healthcare spending. Rapidly developing the economy, increasing healthcare expenditure, and government initiatives for research & development are projected to drive the market in China and India over the assessment period. Alongside, there is a huge growth outlook for the market in the developing countries as these countries are encouraging research and development in healthcare management.

Browse Complete 90+ Pages Premium Research Report Enabled with 40+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/mastitis-market-5379

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mastitis Market 2019 Share Analysis with Pfizer, Novartis AG, Sanofi S.A., AstraZeneca, Genentech Etc. Till 2023 here

News-ID: 1619815 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Mastitis

Bovine Mastitis Market Is Booming So Rapidly | Neogen, Vetoquinol, Dechra
The "Bovine Mastitis Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bovine Mastitis Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Zoetis,
Bovine Mastitis Market to Witness Stunning Growth | Elanco, Ceva, Virbac
A new business intelligence report released by USD Analytics with title "Global Bovine Mastitis Market Report 2030 " has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The Global Bovine Mastitis Market Report offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary
Bovine Mastitis Market: Current Trends and Future Prospects
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. • CAGR: 6.3% • Current Market Size: USD 0.54 Billion • Forecast Growing Region: APAC • Largest Market: North America • Projection Time: 2021- 2031 • Base Year: 2021 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988 Bovine mastitis, an inflammatory condition of the mammary gland in dairy cows, poses
Global Bovine Mastitis Market: Prevalence, Challenges, and Opportunities
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. • CAGR: 6.3% • Current Market Size: USD 0.54 Billion • Forecast Growing Region: APAC • Largest Market: North America • Projection Time: 2021- 2031 • Base Year: 2021 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988 Bovine mastitis is a prevalent and economically significant disease affecting dairy cattle worldwide.
Emerging Therapies and Innovations in the Bovine Mastitis Market
Bovine mastitis, a common and costly disease affecting dairy cattle, continues to be a significant challenge for the dairy industry worldwide. It is characterized by inflammation of the udder tissue, leading to reduced milk production, decreased milk quality, and increased treatment costs. The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022
Demand for Safe and Quality Milk Boosts Bovine Mastitis Market
Bovine mastitis is a common and serious disease that affects dairy cows. It is an inflammatory response of the udder tissue, caused by bacteria or other pathogens that infect the cow's mammary gland. Mastitis can cause milk production to decrease, and the milk produced can be of poor quality and even unsafe for human consumption. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 2023: https://www.alliedmarketresearch.com/request-sample/17988 The bovine mastitis market was valued at